Asthma and Respiratory Disorders News

Moderate levels of ozone and fine particulate matter were associated with nonviral asthma attacks among children and adolescents living in low-income urban areas, according to a study published in The Lancet Planetary Health.

LOUISVILLE, Ky. — Remote patient monitoring for allergy and asthma treatment is here and will only grow in the future, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.

Nearly 3 years into the pandemic, COVID-19 continues to dominate headlines and research labs as scientists explore therapies that mitigate the impact of the virus, particularly among patients with asthma and allergy.

As asthma affects significant proportions of the population, research strove to improve the lives of these patients in 2022. Here are Healio’s 10 most popular stories about these developments.

The Inflation Reduction Act may have been designed to ease household costs for consumers across the country, but it could have additional benefits for people with asthma and allergies as well, according to the American Lung Association.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, highlights presentations from the CHEST Annual Meeting discussing biologic choice — particularly tezepelumab — in patients with severe asthma.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, discusses CHEST Annual Meeting presentations that focused on the role of dupilumab in asthma treatment.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, speaks about a CHEST Annual Meeting session in which he took part that was focused on asthma and COPD overlap.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, discusses a CHEST Annual Meeting symposium in which he participated that addressed choice of biologic in severe asthma.